Rainbow Children's Medicare Q2 FY27 Revenue Up 23% to ₹5,480 Mn; Expands Network
Rainbow Children's Medicare reported Q2 FY27 revenue of ₹5,480 million (up 23% YoY) and H1 FY27 revenue of ₹10,180 million (up 27.6% YoY). EBITDA and PAT also showed double-digit growth. The company expanded its network with new hospitals in Nellore and Guntur and appointed Sudarshan Patodia as Group CFO. Several new projects are in various stages of development.
The announcement includes significant financial performance improvements, strategic expansion initiatives, and new project developments, which are material to the company's growth and investor outlook.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT, along with successful network expansion and strategic appointments, indicating positive business performance and future growth prospects.
Rainbow Children’s Medicare Limited (RCML) announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported a robust performance with a 23% year-on-year revenue growth for the quarter, reaching ₹5,480 million (₹548 crore). EBITDA saw a 14.2% increase to ₹1,700 million (₹170 crore), and Profit After Tax (PAT) grew by 10.9% to ₹839 million (₹83.9 crore).
For the half-year ended September 30, 2026, revenue increased by 27.6% to ₹10,180 million (₹1,018 crore), with EBITDA growing by 20.6% to ₹3,046 million (₹304.6 crore) and PAT by 13.1% to ₹1,464 million (₹146.4 crore).
The company has strengthened its presence in Andhra Pradesh with the commencement of operations at a newly acquired 70-bed hospital in Nellore and a new 50-bed hospital in Guntur. Rainbow also plans to establish a specialty pediatric hospital in Amaravati, Andhra Pradesh, with an initial capacity of 150 beds, following land allotment by the government. The company has also appointed Mr. Sudarshan Patodia as its new Group Chief Financial Officer (CFO).
New hospital projects are on track, with Indore expected to commence operations in Q3 FY27, Malad (Mumbai) in Q1 FY28, Coimbatore and Gurugram (Sector 56) in Q3 FY28, Gurugram (Sector 44) in Q1 FY29, and Pune and Seegehalli in FY29.
Rainbow maintained a strong balance sheet with ₹5,428 million (₹542.8 crore) in cash, cash equivalents, fixed deposits, and mutual fund investments as of September 30, 2026, sufficient for planned capital expenditures. Capital expenditure for the quarter was ₹819 million (₹81.9 crore).
Dr. Ramesh Kancharla, Chairman & Managing Director, highlighted the continued demand for specialized pediatric and women's healthcare and the expansion in Andhra Pradesh. Mr. Abarali Dalal, CEO, emphasized the consistent revenue growth and operational efficiencies, expressing optimism for the remainder of the year.
What to do with a filing like this
Rainbow Childrens Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rainbow Childrens Medicare Limited. Read the original for the full detail.